New product distributor Epitique UK has become the official supplier of E.P.T.Q, a dermal filler range produced by Korean aesthetics company Jetema.
The company explains that the CE-approved range is formulated using high purity hyaluronic acid, which they say aids in the prevention of swelling, and contains less than 0.1 EU/ml of endotoxin.
The filler range offers a choice of three consistencies, designed for treating different areas of the face. According to Epitique, the S100 is for treating the superficial dermis, the S300 for the mid dermis, and the S500 for injecting the deep subcutaneous. All the fillers in the range contain lidocaine.
Jody Latham, founder of Epitique UK, commented, “We are thrilled to have signed a partnership to exclusively distribute E.P.T.Q in the UK and Ireland, as well UK Channel Islands. These products mark a major gear change in the evolution of the medical aesthetics industry over here and I’m delighted we’re going to be the ones to bring these to the market.”